¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ qE=OQs9  
1yc@q8  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© =LA@E&,j  
S3wH M  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© fdW={}~  
o)WSMV(&f  
1.Co-stimulators (or co-stimulating molecules) o|C{ s   
~cw wB{  
2.NK-kB _"`h~jB  
Ry3 f'gx  
3.Immunoglobulin superfamily *h9vMks o  
OSk9Eb4ld  
4.antigen-presenting cell (APC) {*Pp^ r  
N4-J !r@#~  
5.death domain #m>mYp8E.5  
7 i /Cax  
6.CCR and CXCR YZ@-0_Z  
2O/_hv.  
7.Lectin (or mitogen) *Cw2h  
[DwB7l)O(  
8.Clusters of differentiation, CD) ^ EOjq  
566Qik w2  
9.B7 family ri ~2t3gg  
/ jD'o>  
10.Cytotoxic T lymphocyte, CTL) mZyTo/\0  
q0wVV  
11.IL-15 and IL-15 receptor (IL-15R) 6tg uy  
-}@9lhS,  
12.MHC restriction Rd)QVEk>SD  
O [/~V=  
13.Affinity-chromatography %L3]l  
uc_ X;M;  
14.Cyctosprin A, CsA pC6_ jIZ  
OjZ@_V:  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Ee O{G*pq  
I1g u<a  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 0N xaQ`\  
scdT/|(U$  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 #_d%hr~d  
+-hmITJ v  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ~J|0G6H  
7u zN/LAF  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ L" o6)N  
)Ii=8etdv  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© X\;y;pmRH  
mWh:,[o  
ÃâÒßѧרҵ£º 5GKz@as8  
}^H_|;e1p  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ qVfOf\x.e  
/vu7;xVG  
Ïû»¯ÄÚ¿Æ£º rZLMY M  
>_@J&vC  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£  :z[SI{Y  
=6Z 1yw7s  
ѪҺ²¡Ñ§×¨Òµ£º m\(a{x  
ek9%Xk8  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
5+2=? ÕýÈ·´ð°¸:7
°´"Ctrl+Enter"Ö±½ÓÌá½»